作者
- Armstrong, P.W. (35)
- Braunwald, E. (13)
- Califf, R.M. (28)
- Gibson, C.M. (13)
- Granger, C.B. (23)
- Harrington, R.A. (15)
- Newby, L.K. (14)
- Topol, E.J. (11)
- Van de Werf, F. (82)
- White, H.D. (14)
|
總筆數:89
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Randomized coronary patency trial of double-bolus recombinantstaphylokinase versus front-loaded alteplase in acute myocardial infarction |
Vanderschueren, S.;Dens, J.;Kerdsinchai, P.;Desmet, W.;Vrolix, M.;De Man, F.;Van den Heuvel, P.;Hermans, L.;Collen, D.;Van de Werf, F.; |
American Heart Journal |
1997-08-01 |
查看 |
| Rationale and clinical evidence for the use of GP IIb/IIIa inhibitorsin acute coronary syndromes |
Braunwald, E.;Maseri, A.;Armstrong, P.W.;Califf, R.M.;Gibler, W.;Hamm, C.W.;Simoons, M.L.;Van de Werf, F.; |
American Heart Journal |
1998-04-01 |
查看 |
| Death and nonfatal reinfarction within the first 24 hours afterpresentation with an acute coronary syndrome: Experience from GUSTO-IIb |
For the GUSTO-IIb Investigators;Kleiman, N.S.;Granger, C.B.;White, H.D.;Armstrong, P.;Ardissino, D.;Van de Werf, F.;Zoldeyhi, P.;Thompson, T.D.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
1999-01-01 |
查看 |
| Death and nonfatal reinfarction within the first 24 hours afterpresentation with an acute coronary syndrome: Experience from GUSTO-IIb |
For the GUSTO-IIb Investigators;Kleiman, N.S.;Granger, C.B.;White, H.D.;Armstrong, P.;Ardissino, D.;Van de Werf, F.;Zoldeyhi, P.;Thompson, T.D.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
1999-01-01 |
查看 |
| Death and nonfatal reinfarction within the first 24 hours afterpresentation with an acute coronary syndrome: Experience from GUSTO-IIb |
For the GUSTO-IIb Investigators;Kleiman, N.S.;Granger, C.B.;White, H.D.;Armstrong, P.;Ardissino, D.;Van de Werf, F.;Zoldeyhi, P.;Thompson, T.D.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
1999-01-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| What do new lytics add to t-PA? |
Van de Werf, F.; |
American Heart Journal |
1999-08-01 |
查看 |
| What do new lytics add to t-PA? |
Van de Werf, F.; |
American Heart Journal |
1999-08-01 |
查看 |
| Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to AvoidVascular Occlusion (BRAVO) trial |
Topol, E.J.;Easton, J.;Amarenco, P.;Califf, R.;Harrington, R.;Graffagnino, C.;Davis, S.;Diener, H.C.;Ferguson, J.;Fitzgerald, D.;Shuaib, A.;Koudstaal, P.J.;Theroux, P.;Van de Werf, F.;Willerson, J.T.;Chan, R.;Samuels, R.;Ilson, B.;Granett, J.; |
American Heart Journal |
2000-06-01 |
查看 |
| Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale anddesign |
Pfeffer, M.A.;McMurray, J.;Leizorovicz, A.;Maggioni, A.P.;Rouleau, J.-L.;Van de Werf, F.;Henis, M.;Neuhart, E.;Gallo, P.;Edwards, S.;Sellers, M.A.;Velazquez, E.;Califf, R.;for the VALIANT Investigators*; |
American Heart Journal |
2000-11-01 |
查看 |
| Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale anddesign |
Pfeffer, M.A.;McMurray, J.;Leizorovicz, A.;Maggioni, A.P.;Rouleau, J.-L.;Van de Werf, F.;Henis, M.;Neuhart, E.;Gallo, P.;Edwards, S.;Sellers, M.A.;Velazquez, E.;Califf, R.;for the VALIANT Investigators*; |
American Heart Journal |
2000-11-01 |
查看 |
| Determination of a weight-adjusted dose of TNK-tissue plasminogen activator |
Wang-Clow, F.;Fox, N.L.;Cannon, C.P.;Gibson, C.M.;Berioli, S.;Bluhmki, E.;Danays, T.;Braunwald, E.;Van de Werf, F.;Stump, D.C.; |
American Heart Journal |
2001-01-01 |
查看 |
| Determination of a weight-adjusted dose of TNK-tissue plasminogenactivator |
Wang-Clow, F.;Fox, N.L.;Cannon, C.P.;Gibson, C.;Berioli, S.;Bluhmki, E.;Danays, T.;Braunwald, E.;Van de Werf, F.;Stump, D.C.; |
American Heart Journal |
2001-01-01 |
查看 |
| Determination of a weight-adjusted dose of TNK-tissue plasminogenactivator |
Wang-Clow, F.;Fox, N.L.;Cannon, C.P.;Gibson, C.;Berioli, S.;Bluhmki, E.;Danays, T.;Braunwald, E.;Van de Werf, F.;Stump, D.C.; |
American Heart Journal |
2001-01-01 |
查看 |
| Abciximab and early adjunctive percutaneous coronary intervention areassociated with improved ST-segment resolution after thrombolysis:Observations from the TIMI 14 Trial |
de Lemos, J.A.;Gibson, C.M.;Antman, E.M.;Murphy, S.A.;Morrow, D.A.;Schuhwerk, K.C.;Schweiger, M.;Coussement, P.;Van de Werf, F.;Braunwald, E.;for the TIMI 14 Investigators; |
American Heart Journal |
2001-04-01 |
查看 |
| Abciximab and early adjunctive percutaneous coronary intervention areassociated with improved ST-segment resolution after thrombolysis:Observations from the TIMI 14 Trial |
de Lemos, J.A.;Gibson, C.M.;Antman, E.M.;Murphy, S.A.;Morrow, D.A.;Schuhwerk, K.C.;Schweiger, M.;Coussement, P.;Van de Werf, F.;Braunwald, E.;for the TIMI 14 Investigators; |
American Heart Journal |
2001-04-01 |
查看 |
| Predictors of left ventricular function after acute myocardial infarction:Effects of time to treatment, patency, and body mass index |
Lundergan, C.F.;Ross, A.M.;McCarthy, W.F.;Reiner, J.S.;Boyle, D.;Fink, C.;Califf, R.M.;Topol, E.J.;Simoons, M.L.;Van Den Brand, M.;Van de Werf, F.;Coyne, K.S.;for the GUSTO-I Angiographic Investigators; |
American Heart Journal |
2001-07-01 |
查看 |
| Predictors of left ventricular function after acute myocardialinfarction: Effects of time to treatment, patency, and body mass index |
Lundergan, C.F.;Ross, A.M.;McCarthy, W.F.;Reiner, J.S.;Boyle, D.;Fink, C.;Califf, R.M.;Topol, E.J.;Simoons, M.L.;Van Den Brand, M.;Van de Werf, F.;Coyne, K.S.;for the GUSTO-I Angiographic Investigators; |
American Heart Journal |
2001-07-01 |
查看 |
| New data in treatment of acute coronary syndromes |
Van de Werf, F.; |
American Heart Journal |
2001-08-01 |
查看 |
| New data in treatment of acute coronary syndromes |
Van de Werf, F.; |
American Heart Journal |
2001-08-01 |
查看 |
| Low-molecular-weight heparin therapy for non-ST-elevation acute coronarysyndromes and during percutaneous coronary intervention: An expertconsensus^* |
Kereiakes, D.J.;Montalescot, G.;Antman, E.M.;Cohen, M.;Darius, H.;Ferguson, J.J.;Grines, C.;Karsch, K.R.;Kleiman, N.S.;Moliterno, D.J.;Steg, P.-G.;Teirstein, P.;Van de Werf, F.;Wallentin, L.; |
American Heart Journal |
2002-10-01 |
查看 |
| Low-molecular-weight heparin therapy for non-ST-elevation acutecoronary syndromes and during percutaneous coronary intervention: An expertconsensus^* |
Kereiakes, D.J.;Montalescot, G.;Antman, E.M.;Cohen, M.;Darius, H.;Ferguson, J.J.;Grines, C.;Karsch, K.R.;Kleiman, N.S.;Moliterno, D.J.;Steg, P.G.;Teirstein, P.;Van de Werf, F.;Wallentin, L.; |
American Heart Journal |
2002-10-01 |
查看 |
| Frequency, patient characteristics, and outcomes of mild-to-moderate heartfailure complicating ST-segment elevation acute myocardial infarction:Lessons from 4 international fibrinolytic therapy trials |
Hasdai, D.;Topol, E.J.;Kilaru, R.;Battler, A.;Harrington, R.A.;Vahanian, A.;Ohman, E.M.;Granger, C.B.;Van de Werf, F.;Simoons, M.L.;O'Connor, C.M.;Holmes, D.R.; |
American Heart Journal |
2003-01-01 |
查看 |
| Effect of tenecteplase versus alteplase on platelets during the first 3hours of treatment for acute myocardial infarction: The Assessment of theSafety and Efficacy of a New Thrombolytic Agent (ASSENT-2) plateletsubstudy |
Serebruany, V.L.;Malinin, A.I.;Callahan, K.P.;Binbrek, A.;Van de Werf, F.;Alexander, J.H.;Granger, C.B.;Gurbel, P.A.; |
American Heart Journal |
2003-04-01 |
查看 |
| One-year follow-up of the ASSENT-2 trial: A double-blind, randomizedcomparison of single-bolus tenecteplase and front-loaded alteplase in16,949 patients with ST-elevation acute myocardial infarction |
Sinnaeve, P.;Alexander, J.;Belmans, A.;Bogaerts, K.;Langer, A.;Diaz, R.;Ardissino, D.;Vahanian, A.;Pehrsson, K.;Armstrong, P.;Van de Werf, F.;ASSENT-2 Investigators; |
American Heart Journal |
2003-07-01 |
查看 |
| One-year follow-up of the ASSENT-2 trial: A double-blind, randomizedcomparison of single-bolus tenecteplase and front-loaded alteplase in16,949 patients with ST-elevation acute myocardial infarction |
Sinnaeve, P.;Alexander, J.;Belmans, A.;Bogaerts, K.;Langer, A.;Diaz, R.;Ardissino, D.;Vahanian, A.;Pehrsson, K.;Armstrong, P.;Van de Werf, F.;ASSENT-2 Investigators; |
American Heart Journal |
2003-07-01 |
查看 |
| Collaborative angiographic patency trial of recombinant staphylokinase(CAPTORS II) |
Armstrong, P.W.;Burton, J.;Pakola, S.;Molhoek, P.G.;Betriu, A.;Tendera, M.;Bode, C.;Adgey, A.A.J.;Bar, F.;Vahanian, A.;Van de Werf, F.;CAPTORS II Investigators; |
American Heart Journal |
2003-09-01 |
查看 |
| Does 24-hour ST-segment resolution postfibrinolysis add prognostic value toa Q wave? An ASSENT 2 electrocardiographic substudy |
Lockwood, E.;Fu, Y.;Wong, B.;Van de Werf, F.;Granger, C.B.;Armstrong, P.W.;Goodman, S.G.;ASSENT-2 Investigators; |
American Heart Journal |
2003-10-01 |
查看 |
| Does 24-hour ST-segment resolution postfibrinolysis add prognostic value toa Q wave? An ASSENT 2 electrocardiographic substudy |
Lockwood, E.;Fu, Y.;Wong, B.;Van de Werf, F.;Granger, C.B.;Armstrong, P.W.;Goodman, S.G.;ASSENT-2 Investigators; |
American Heart Journal |
2003-10-01 |
查看 |
| Global patterns of use of antithrombotic and antiplatelet therapies inpatients with acute coronary syndromes: insights from the Global Registryof Acute Coronary Events (GRACE) |
Budaj, A.;Brieger, D.;Steg, P.G.;Goodman, S.G.;Dabbous, O.H.;Fox, K.A.A.;Avezum, A.;Cannon, C.P.;Mazurek, T.;Flather, M.D.;Van De Werf, F.;GRACE Investigators; |
American Heart Journal |
2003-12-01 |
查看 |
| Association of diabetes mellitus and glycemic control strategies withclinical outcomes after acute coronary syndromes |
McGuire, D.K.;Newby, L.K.;Bhapkar, M.V.;Moliterno, D.J.;Hochman, J.S.;Klein, W.W.;Weaver, W.D.;Pfisterer, M.;Corbalan, R.;Dellborg, M.;Granger, C.B.;Van De Werf, F.;Topol, E.J.;Califf, R.M.;SYMPHONY and 2nd SYMPHONY Investigators; |
American Heart Journal |
2004-02-01 |
查看 |
| Association of diabetes mellitus and glycemic control strategies withclinical outcomes after acute coronary syndromes |
McGuire, D.K.;Newby, L.K.;Bhapkar, M.V.;Moliterno, D.J.;Hochman, J.S.;Klein, W.W.;Weaver, W.D.;Pfisterer, M.;Corbalan, R.;Dellborg, M.;Granger, C.B.;Van De Werf, F.;Topol, E.J.;Califf, R.M.;SYMPHONY and 2nd SYMPHONY Investigators; |
American Heart Journal |
2004-02-01 |
查看 |
| Outcome of ST-elevation myocardial infarction treated with thrombolysis inthe unselected population is vastly different from samples of eligiblepatients in a large-scale clinical trial |
Bjorklund, E.;Lindahl, B.;Stenestrand, U.;Swahn, E.;Dellborg, M.;Pehrsson, K.;Van De Werf, F.;Wallentin, L.;Swedish ASSENT-2 and RIKS-HIA Investigators; |
American Heart Journal |
2004-10-01 |
查看 |
| Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): Amulticenter, randomized, double-blind, parallel-group, placebo-controlledstudy of pexelizumab in patients with acute myocardial infarctionundergoing primary percutaneous coronary intervention |
Armstrong, P.W.;Adams, P.X.;Al-Khalidi, H.R.;Hamm, C.;Holmes, D.;O'Neill, W.;Todaro, T.G.;Vahanian, A.;Van de Werf, F.;Granger, C.B.;on behalf of the APEX-AMI Steering Committee; |
American Heart Journal |
2005-03-01 |
查看 |
| Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): Amulticenter, randomized, double-blind, parallel-group, placebo-controlledstudy of pexelizumab in patients with acute myocardial infarctionundergoing primary percutaneous coronary intervention |
Armstrong, P.W.;Adams, P.X.;Al-Khalidi, H.R.;Hamm, C.;Holmes, D.;O'Neill, W.;Todaro, T.G.;Vahanian, A.;Van de Werf, F.;Granger, C.B.;on behalf of the APEX-AMI Steering Committee; |
American Heart Journal |
2005-03-01 |
查看 |
| Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): Amulticenter, randomized, double-blind, parallel-group, placebo-controlledstudy of pexelizumab in patients with acute myocardial infarctionundergoing primary percutaneous coronary intervention |
on behalf of the APEX-AMI Steering Committee;Armstrong, P.W.;Adams, P.X.;Al-Khalidi, H.R.;Hamm, C.;Holmes, D.;O'Neill, W.;Todaro, T.G.;Vahanian, A.;Van de Werf, F.;Granger, C.B.; |
American Heart Journal |
2005-03-01 |
查看 |
| Economic analysis of the Assessment of the Safety and Efficacy of a NewThrombolytic Regimen (ASSENT-3) study: Costs of reperfusion strategies inacute myocardial infarction |
Kaul, P.;Armstrong, P.W.;Cowper, P.A.;Eisenstein, E.L.;Granger, C.B.;Van de Werf, F.;Mark, D.B.; |
American Heart Journal |
2005-04-01 |
查看 |
| Economic analysis of the Assessment of the Safety and Efficacy of a NewThrombolytic Regimen (ASSENT-3) study: Costs of reperfusion strategies inacute myocardial infarction |
Kaul, P.;Armstrong, P.W.;Cowper, P.A.;Eisenstein, E.L.;Granger, C.B.;Van de Werf, F.;Mark, D.B.; |
American Heart Journal |
2005-04-01 |
查看 |
| The Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment ElevationAcute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlledtrial evaluating the clinical benefits of early front-loaded eptifibatidein the treatment of patients with non-ST-segment elevation acute coronarysyndrome-Study design and rationale |
on behalf of the EARLY ACS Steering Committee;Giugliano, R.P.;Newby, L.K.;Harrington, R.A.;Gibson, C.M.;Van de Werf, F.;Armstrong, P.;Montalescot, G.;Gilbert, J.;Strony, J.T.;Califf, R.M.;Braunwald, E.; |
American Heart Journal |
2005-06-01 |
查看 |
| The Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment ElevationAcute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlledtrial evaluating the clinical benefits of early front-loaded eptifibatidein the treatment of patients with non-ST-segment elevation acute coronarysyndrome-Study design and rationale |
on behalf of the EARLY ACS Steering Committee;Giugliano, R.P.;Newby, L.K.;Harrington, R.A.;Gibson, C.M.;Van de Werf, F.;Armstrong, P.;Montalescot, G.;Gilbert, J.;Strony, J.T.;Califf, R.M.;Braunwald, E.; |
American Heart Journal |
2005-06-01 |
查看 |
| Tenecteplase and tirofiban in ST-segment elevation acute myocardialinfarction: Results of a randomized trial |
for the FASTER (TIMI 24) Investigators;Ohman, E.M.;Van de Werf, F.;Antman, E.M.;Califf, R.M.;de Lemos, J.A.;Gibson, C.M.;Oliverio, R.L.;Harrelson, L.;McCabe, C.;DiBattiste, P.;Braunwald, E.; |
American Heart Journal |
2005-07-01 |
查看 |
| Tenecteplase and tirofiban in ST-segment elevation acute myocardialinfarction: Results of a randomized trial |
for the FASTER (TIMI 24) Investigators;Ohman, E.M.;Van de Werf, F.;Antman, E.M.;Califf, R.M.;de Lemos, J.A.;Gibson, C.M.;Oliverio, R.L.;Harrelson, L.;McCabe, C.;DiBattiste, P.;Braunwald, E.; |
American Heart Journal |
2005-07-01 |
查看 |
| Unraveling the spectrum of left bundle branch block in acute myocardialinfarction: Insights from the Assessment of the Safety and Efficacy of aNew Thrombolytic (ASSENT 2 and 3) trials |
for the ASSENT 2 and 3 Investigators;Al-Faleh, H.;Fu, Y.;Wagner, G.;Goodman, S.;Sgarbossa, E.;Granger, C.;Van de Werf, F.;Wallentin, L.;W. Armstrong, P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Unraveling the spectrum of left bundle branch block in acute myocardialinfarction: Insights from the Assessment of the Safety and Efficacy of aNew Thrombolytic (ASSENT 2 and 3) trials |
for the ASSENT 2 and 3 Investigators;Al-Faleh, H.;Fu, Y.;Wagner, G.;Goodman, S.;Sgarbossa, E.;Granger, C.;Van de Werf, F.;Wallentin, L.;W. Armstrong, P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Cardiac tamponade in the fibrinolytic era: Analysis of >100000 patientswith ST-segment elevation myocardial infarction |
Patel, M.R.;Meine, T.J.;Lindblad, L.;Griffin, J.;Granger, C.B.;Becker, R.C.;Van de Werf, F.;White, H.;Califf, R.M.;Harrington, R.A.; |
American Heart Journal |
2006-02-01 |
查看 |
| What is the frequency and functional and clinical significance ofcomplex lesions in non-infarct-related arteries after fibrinolysis foracute ST-elevation myocardial infarction? |
for the CAPTORS II Investigators;Kim, D.H.;Burton, J.R.;Fu, Y.;Lindholm, L.;Van de Werf, F.;Armstrong, P.W.; |
American Heart Journal |
2006-03-01 |
查看 |
| What is the frequency and functional and clinical significance ofcomplex lesions in non-infarct-related arteries after fibrinolysis foracute ST-elevation myocardial infarction? |
for the CAPTORS II Investigators;Kim, D.H.;Burton, J.R.;Fu, Y.;Lindholm, L.;Van de Werf, F.;Armstrong, P.W.; |
American Heart Journal |
2006-03-01 |
查看 |
| What is the frequency and functional and clinical significance ofcomplex lesions in non-infarct-related arteries after fibrinolysis foracute ST-elevation myocardial infarction? |
for the CAPTORS II Investigators;Kim, D.H.;Burton, J.R.;Fu, Y.;Lindholm, L.;Van de Werf, F.;Armstrong, P.W.; |
American Heart Journal |
2006-03-01 |
查看 |
| What is the frequency and functional and clinical significance ofcomplex lesions in non-infarct-related arteries after fibrinolysis foracute ST-elevation myocardial infarction? |
for the CAPTORS II Investigators;Kim, D.H.;Burton, J.R.;Fu, Y.;Lindholm, L.;Van de Werf, F.;Armstrong, P.W.; |
American Heart Journal |
2006-03-01 |
查看 |
| Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectinantagonist, as an adjunct to thrombolysis in acute myocardial infarction.The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial |
for the PSALM investigators;Mertens, P.;Maes, A.;Nuyts, J.;Belmans, A.;Desmet, W.;Esplugas, E.;Charlier, F.;Figueras, J.;Sambuceti, G.;Schwaiger, M.;Mortelmans, L.;Van de Werf, F.; |
American Heart Journal |
2006-07-01 |
查看 |
|
|
|
